Pure Global AI
NCT06384300Not yet recruiting

Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China

Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China: An Individual Level Randomized Controlled Trial Study Protocol
Peking UniversityClinicalTrials.govother
Study focus
Disease/Condition
Gastric Cancer
Drug/Device/Intervention
Financial Incentives
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Peking University
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2024
End date
Jul 31, 2027
Enrollment
5000 participants
Primary outcome

Primary Outcome 1,Primary Outcome 2

Summary

Gastric cancer, also known as stomach cancer, is a serious disease that affects the stomach.
 It's one of the most common types of cancer, and sadly, many people die from it each year.
 But there's hope! We can catch gastric cancer early with a special test called endoscopy.
 This test helps doctors find cancer or pre-cancerous changes in the stomach early, when it's
 easier to treat. However, not enough people get this test, especially in places where
 healthcare isn't easily available. That's why we're doing this study.
 
 We want to find out if we can encourage more people to get the endoscopy test for gastric
 cancer. We're going to try two different ways to encourage people to get the test. First,
 we'll give some people money or other incentives to help cover the costs of getting the test.
 Second, we'll give others information and support to help them understand why the test is
 important and how it can help them.
 
 We'll be doing this study in two provinces in China, where gastric cancer is a big problem.
 We'll ask thousands of people to join the study, and we'll randomly assign them to one of the
 two groups. Then, we'll see if more people in one group get the endoscopy test compared to
 the other group.
 
 Our hope is that by finding out what works best, we can help more people catch gastric cancer
 early and get the treatment they need. This could save many lives and make a big difference
 in fighting this disease.

ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06384300
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06384300 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking University and is currently Not yet recruiting. The study focuses on Gastric Cancer. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.